期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 153, 期 -, 页码 2-17出版社
ELSEVIER
DOI: 10.1016/j.addr.2020.04.008
关键词
5-aminolevulinic acid; 5-fluorouricil; Actinic keratosis; Antioxidants; Basal cell carcinoma; Cosmeceutical; Cosmetic; Elongated microparticles; Foroderm; Glycolic acid; Hyaluronic acid; Hydroxy acids; Imiquimod; Ingenol mebutate; Iontophoresis; Methyl aminolevulinate; Microneedle; Non-melanoma skin cancer; Photoaged skin; Physical drug delivery enhancement
资金
- Australian National Health and Medical Research Council Career Development Fellowship Level II [APP1109749]
This review analyses physical drug delivery enhancement technologies with a focus on improving UV damaged skin, actinic keratoses and non-melanoma skin cancer treatment. In recent years, physical drug delivery enhancement has been shown to enhance cosmeceutical and skin cancer treatment efficacy, but there are pros and cons to each approach which we discuss in detail. Mechanisms of action, clinical efficacy, experimental design, outcomes in academic publications, clinical trial reports and patents are explored to evaluate each technology with a critical, translation focused lens. We conclude that the commercial success of cosmeceutical applications, e.g. microneedles, will drive further innovation in this arena that will impact how actinic keratoses and non melanoma skin cancers are clinically managed. Crown Copyright (c) 2020 Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据